PARNAX LAB
Back to Balance Sheet
|
PARNAX LAB Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.46 Cr | ₹0.94 Cr | ₹2.74 Cr | ₹2.74 Cr | ₹0.73 Cr |
What is the latest Contingent Liabilities ratio of PARNAX LAB ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1.46 Cr |
| Mar2024 | ₹0.94 Cr |
| Mar2023 | ₹2.74 Cr |
| Mar2022 | ₹2.74 Cr |
| Mar2021 | ₹0.73 Cr |
How is Contingent Liabilities of PARNAX LAB Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.46 Cr | 56.14 | |
| Mar2024 | ₹0.94 Cr | -65.84 | |
| Mar2023 | ₹2.74 Cr | 0.00 | |
| Mar2022 | ₹2.74 Cr | 274.73 | |
| Mar2021 | ₹0.73 Cr | - | |
Compare Contingent Liabilities of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹145.2 Cr | 3.4% | 10.1% | -18.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.5% | 1.8% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | -0.3% | -1.3% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 4.4% | 6% | 27.7% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | 1% | -3% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | 1.1% | 8% | 3.8% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | 3.4% |
10.1% |
-18.3% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses